We recently participated in Mediaplanet Canada’s Rare Diseases campaign in which many industry leaders united to provide Canadians with a comprehensive ... Read More
Category 1 requirements for products that undergo a tailored CDR review have been revised. Submissions for new combination products (funded ... Read More
CADTH will be implementing an application fee for manufacturer applications filed with the pan-Canadian Oncology Drug Review (pCODR). The proposed ... Read More
